Literature DB >> 4008402

Physiological effects of high-P50 erythrocyte transfusion on piglets.

B P Teisseire, C Ropars, M O Vallez, R A Herigault, C Nicolau.   

Abstract

Rightward shifts of the O2 dissociation curve (ODC) were experimentally obtained in lysed and resealed erythrocytes following encapsulation of inositol hexaphosphate (IHP). This continuous lysing and resealing procedure led to in vitro P50 (Po2 at 50% hemoglobin saturation) increases up to 80 Torr (pH, 7.40; Pco2, 40 Torr; temp, 37 degrees C) for both human and pig erythrocytes. The Hill number of the transformed blood decreased when IHP was fixed on the hemoglobin, but the sigmoid shape of the ODC was maintained. The O2 hemoglobin binding capacity and the mean corpuscular hemoglobin content were found unchanged by the experimental procedure in human and pig erythrocytes. Isovolumic exchange transfusion of high-P50 erythrocytes in anesthetized and ambient air-ventilated piglets (n = 6) led to substantial in vivo P50 increases (range, 8-19 Torr). The rightward shift of the ODC was concomitant with an increase of the arterial Po2 and of the arteriovenous O2 content difference, 19 and 59% respectively above their control values. The mixed-venous Po2 (PVO2) remained unchanged. The cardiac output was shown to be inversely related to the P50 value. In spite of the O2-transport reduction (37%), O2 consumption was maintained due to enhanced O2 extraction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4008402     DOI: 10.1152/jappl.1985.58.6.1810

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  10 in total

1.  Reduced parasitemia observed with erythrocytes containing inositol hexaphosphate.

Authors:  C L Mintzer; P Deloron; A Rice-Ficht; D Durica; D K Struck; C A Roessner; C Nicolau; G M Ihler
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

2.  Conversion of encapsulated 5-fluoro-2'-deoxyuridine 5'-monophosphate to the antineoplastic drug 5-fluoro-2'-deoxyuridine in human erythrocytes.

Authors:  A De Flora; E Zocchi; L Guida; C Polvani; U Benatti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

3.  Suppression of hypoxia-induced HIF-1alpha and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes.

Authors:  Claudine Kieda; Ruth Greferath; Claire Crola da Silva; Konstantina C Fylaktakidou; Jean-Marie Lehn; Claude Nicolau
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-06       Impact factor: 11.205

4.  Long-term physiological effects of enhanced O2 release by inositol hexaphosphate-loaded erythrocytes.

Authors:  B Teisseire; C Ropars; M C Villeréal; C Nicolau
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

5.  Hyperoxia-induced alterations in cardiovascular function and autonomic control during return to normoxic breathing.

Authors:  Yoann Gole; Ombeline Gargne; Mathieu Coulange; Jean-Guillaume Steinberg; Malika Bouhaddi; Yves Jammes; Jacques Regnard; Alain Boussuges
Journal:  Eur J Appl Physiol       Date:  2010-11-11       Impact factor: 3.078

Review 6.  Oxygen transport in blood at high altitude: role of the hemoglobin-oxygen affinity and impact of the phenomena related to hemoglobin allosterism and red cell function.

Authors:  Michele Samaja; Tiziano Crespi; Marco Guazzi; Kim D Vandegriff
Journal:  Eur J Appl Physiol       Date:  2003-09-18       Impact factor: 3.078

7.  Modulation of perfusion and oxygenation by red blood cell oxygen affinity during acute anemia.

Authors:  Pedro Cabrales; Amy G Tsai; Marcos Intaglietta
Journal:  Am J Respir Cell Mol Biol       Date:  2007-09-20       Impact factor: 6.914

8.  Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate.

Authors:  Andreia Biolo; Ruth Greferath; Deborah A Siwik; Fuzhong Qin; Eugene Valsky; Konstantina C Fylaktakidou; Srinivasu Pothukanuri; Carolina D Duarte; Richard P Schwarz; Jean-Marie Lehn; Claude Nicolau; Wilson S Colucci
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

9.  The influence of haemoglobin affinity for oxygen on tumour radiosensitivity.

Authors:  D G Hirst; P J Wood
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

10.  Treatment of hypoxia-dependent cardiovascular diseases by myo-inositol trispyrophosphate (ITPP)-enhancement of oxygen delivery by red blood cells.

Authors:  Marta Oknińska; Bouchra El-Hafny-Rahbi; Aleksandra Paterek; Urszula Mackiewicz; Claire Crola-Da Silva; Klaudia Brodaczewska; Michał Mączewski; Claudine Kieda
Journal:  J Cell Mol Med       Date:  2020-01-19       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.